38 /100
MEDIUM RISK
Score updated May 30, 2026

DMRA — Damora Therapeutics, Inc. Dilution Risk Tracker

Track DMRA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track DMRA — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
25
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
20%
📉 Score Deterioration 40%
• Score rose 17 points recently (worsening)
🔔 Track DMRA — Get forecast alerts →

💹 Market Data

Market Cap$1.53B
Shares Outstanding61.55M
Float41.22M
Cash$532.90M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

91.0% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track DMRA for full holder detail →

📉 Short Interest

Short Interest1.29M
Days to Cover3.1
% of Float3.1%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2020
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track DMRA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking DMRA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: ADAG AIEV AIP ALLO ALOY
🔬 More Research for DMRA
📊 DMRA FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 DMRA Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.